✦ LIBER ✦

Treatment of Newly Diagnosed Glioblastoma Multiforme with Carmustine, Cisplatin and Etoposide Followed by Radiotherapy. A Phase II Study

✍ Scribed by Ulrik Lassen; Paul E.G. Kristjansen; Aase Wagner; Michael Kostel-janetz; Hans Skovgaard Poulsen

Book ID: 110233563
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 36 KB
Volume: 43
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1006254716877

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of newly diagnosed glioblastom

Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study

✍ Ulrik Lassen; Paul E.G. Kristjansen; Aase Wagner; Michael Kosteljanetz; Hans Sko 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 23 KB

Phase II Study of Chemotherapy with ACNU

Phase II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme

✍ In Sil Choi; Se Hoon Lee; Tae-You Kim; Jae Seug Bang; Sun Ha Paek; Suzy Kim; Il 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 62 KB

Phase II study of temozolomide without r

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population

✍ Carol Alliot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Phase II study of temozolomide without r

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

✍ Olivier-L. Chinot; Maryline Barrie; Elisabeth Frauger; Henry Dufour; Dominique F 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND Currently, the survival of patients age > 70 years with glioblastoma multiforme (GBM) ranges from 4 months to 6 months, although radiotherapy and/or chemotherapy may prolong survival in certain subgroups. Temozolomide is an oral chemotherapeutic agent with efficacy agains

Phase II study of temozolomide and thali

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

✍ Susan M. Chang; Kathleen R. Lamborn; Mary Malec; David Larson; William Wara; Pen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 74 KB

A Phase II Study of Preradiation Chemoth

A Phase II Study of Preradiation Chemotherapy Followed by External Beam Radiotherapy for the Treatment of Patients with Newly Diagnosed Glioblastoma Multiforme: An Eastern Cooperative Oncology Group Study (E2393)

✍ Mark Gilbert; Anne O'Neill; Stuart Grossman; Margaret Grunnet; Minesh Mehta; Ste 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 42 KB